Celldex Therapeutics Stock Forecast

Buy or Hold candidate since Jun 11, 2026 Gain 26.67%

The Celldex Therapeutics stock price fell by -1.09% on the last day (Monday, 6th Jul 2026) from $38.37 to $37.95. During the last trading day the stock fluctuated 3.33% from a day low at $37.26 to a day high of $38.50. The price has risen in 6 of the last 10 days and is up by 17.02% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -262 thousand shares and in total, 439 thousand shares were bought and sold for approximately $16.67 million.

The stockis at the upper part of a very wide and horizontal trend and normally this may pose a good selling opportunity but a break-up through the top trend line at $38.38 will give a strong buy signal and a trend shift could be expected. Given the current horizontal trend, you can expect Celldex Therapeutics stock with a 90% probability to be traded between $29.16 and $38.96 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

CLDX Signals & Forecast

The Celldex Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $36.73 and $32.15. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 02, 2026, and so far it has fallen -1.09%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Celldex Therapeutics stock

Celldex Therapeutics finds support from accumulated volume at $37.21 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.24 between high and low, or 3.33%. For the last week, the stock has had daily average volatility of 5.27%.

The Celldex Therapeutics stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $36.51 (-3.80%) (This stock has high daily movements and this gives high risk. The RSI14 is 81 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (CLDX) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect Celldex Therapeutics to open at $37.90, and during the day (based on 14 day Average True Range), to move between $37.21 and $38.69, which gives a possible trading interval of +/-$1.47 (+/-3.96%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 3.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $38.37 (1.11%) than the support at $37.21 (1.95%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Celldex Therapeutics stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Celldex Therapeutics stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.742 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 7, 2026 - $37.90 ( 0.123%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk